Holliston, MA, United States of America

Tracey Friss

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Berg LLC, Bpgbio, Inc.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tracey Friss. Retrieved from https://idiyas.com/inventor/tracey-friss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tracey Friss: Innovator in Filamin A Binding Proteins

Introduction

Tracey Friss is an accomplished inventor based in Holliston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of filamin A binding proteins. With a total of two patents to his name, Friss has focused on innovative solutions for medical diagnostics.

Latest Patents

Friss's latest patents revolve around filamin A (FLNA) binding proteins. The inventions encompass antibodies to FLNA, which can be either full-length antibodies or antigen-binding portions. These antibodies are designed for use in methods of diagnosis, monitoring, and prognosis of prostate cancer. The detailed methodologies for creating and utilizing these antibodies are also included in his patents.

Career Highlights

Throughout his career, Tracey Friss has worked with notable companies such as Berg LLC and Bpgbio, Inc. His work has been instrumental in advancing research and applications in the field of cancer diagnostics.

Collaborations

Friss has collaborated with talented individuals, including Wenfang Sybil Wu and Shobha Ravipaty. These partnerships have contributed to the success of his innovative projects.

Conclusion

Tracey Friss is a notable inventor whose work on filamin A binding proteins has the potential to impact prostate cancer diagnostics significantly. His contributions to biotechnology continue to pave the way for advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…